Overview: Zytoprotec, established in 2007 in Austria, is a biotechnology enterprise dedicated to applying leading discoveries in cytoprotection to create innovative treatments for significant diseases. The company was founded by a group of experts with extensive backgrounds in business administration, clinical research, pharmaceutical product development, and both company and patent law.
Focus: Industries: Biopharma, Biotechnology
Recent Investment: Received a €2.00M Series A investment on 29 January 2013 from Baxter International.
Slogan: "Redefining Healthcare through Innovative Cytoprotection Solutions."
Conclusion: Zytoprotec is a promising biotechnology startup with a strong emphasis on innovative treatments and a notable investment backing from Baxter International in 2013.